Skip to main content
Gut logoLink to Gut
. 1998 Jul;43(Suppl 1):S61–S65. doi: 10.1136/gut.43.2008.s61

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

F Megraud, H Doermann
PMCID: PMC1766605  PMID: 9764043

Full Text

The Full Text of this article is available as a PDF (84.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell G. D., Bate C. M., Axon A. T., Tildesley G., Kerr G. D., Green J. R., Emmas C. E., Taylor M. D. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther. 1995 Oct;9(5):513–520. doi: 10.1111/j.1365-2036.1995.tb00414.x. [DOI] [PubMed] [Google Scholar]
  2. Bell G. D., Powell K. U., Burridge S. M., Bowden A. N., Rameh B., Bolton G., Purser K., Harrison G., Brown C., Gant P. W. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med. 1993 Nov;86(11):743–750. [PubMed] [Google Scholar]
  3. Bell G. D., Powell K., Burridge S. M., Pallecaros A., Jones P. H., Gant P. W., Harrison G., Trowell J. E. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther. 1992 Aug;6(4):427–435. doi: 10.1111/j.1365-2036.1992.tb00556.x. [DOI] [PubMed] [Google Scholar]
  4. Borody T. J., Andrews P., Fracchia G., Brandl S., Shortis N. P., Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut. 1995 Oct;37(4):477–481. doi: 10.1136/gut.37.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cederbrant G., Kahlmeter G., Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother. 1992 Feb;29(2):115–120. doi: 10.1093/jac/29.2.115. [DOI] [PubMed] [Google Scholar]
  6. De Boer W. A., Driessen W. M., Tytgat G. N. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Dec;9(6):633–638. doi: 10.1111/j.1365-2036.1995.tb00432.x. [DOI] [PubMed] [Google Scholar]
  7. DeCross A. J., Marshall B. J., McCallum R. W., Hoffman S. R., Barrett L. J., Guerrant R. L. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol. 1993 Aug;31(8):1971–1974. doi: 10.1128/jcm.31.8.1971-1974.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Glupczynski Y., Burette A., De Koster E., Nyst J. F., Deltenre M., Cadranel S., Bourdeaux L., De Vos D. Metronidazole resistance in Helicobacter pylori. Lancet. 1990 Apr 21;335(8695):976–977. doi: 10.1016/0140-6736(90)91043-a. [DOI] [PubMed] [Google Scholar]
  9. Glupczynski Y., Burette A. Eradicating Helicobacter pylori. Lancet. 1992 Jan 4;339(8784):54–55. [PubMed] [Google Scholar]
  10. Goodwin C. S., Marshall B. J., Blincow E. D., Wilson D. H., Blackbourn S., Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol. 1988 Feb;41(2):207–210. doi: 10.1136/jcp.41.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harris A. W., Pryce D. I., Gabe S. M., Karim Q. N., Walker M. M., Langworthy H., Baron J. H., Misiewicz J. J. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment Pharmacol Ther. 1996 Dec;10(6):1005–1008. [PubMed] [Google Scholar]
  12. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  13. Lerang F., Moum B., Haug J. B., Tolås P., Breder O., Aubert E., Høie O., Søberg T., Flaaten B., Farup P. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol. 1997 Feb;92(2):248–253. [PubMed] [Google Scholar]
  14. Logan R. P., Gummett P. A., Misiewicz J. J., Karim Q. N., Walker M. M., Baron J. H. One week eradication regimen for Helicobacter pylori. Lancet. 1991 Nov 16;338(8777):1249–1252. doi: 10.1016/0140-6736(91)92111-e. [DOI] [PubMed] [Google Scholar]
  15. Lynch D. A., Sobala G. M., Gallacher B., Dixon M. F., Axon A. T. Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori. J Antimicrob Chemother. 1994 Apr;33(4):877–879. doi: 10.1093/jac/33.4.877. [DOI] [PubMed] [Google Scholar]
  16. Midolo P. D., Lambert J. R., Turnidge J. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol. 1996 Mar;11(3):290–292. doi: 10.1111/j.1440-1746.1996.tb00078.x. [DOI] [PubMed] [Google Scholar]
  17. Mégraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther. 1997 Apr;11 (Suppl 1):43–53. doi: 10.1046/j.1365-2036.11.s1.11.x. [DOI] [PubMed] [Google Scholar]
  18. Noach L. A., Langenberg W. L., Bertola M. A., Dankert J., Tytgat G. N. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis. 1994;26(3):321–327. doi: 10.3109/00365549409011802. [DOI] [PubMed] [Google Scholar]
  19. Rautelin H., Kosunen T. U., Seppälä K. Eradicating Helicobacter pylori. Lancet. 1992 Jan 4;339(8784):55–55. [PubMed] [Google Scholar]
  20. Schütze K., Hentschel E., Hirschl A. M. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia. Eur J Gastroenterol Hepatol. 1996 Jan;8(1):41–46. doi: 10.1097/00042737-199601000-00008. [DOI] [PubMed] [Google Scholar]
  21. Thijs J. C., Van Zwet A. A., Thijs W. J., Van der Wouden E. J., Kooy A. One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance. Aliment Pharmacol Ther. 1997 Apr;11(2):305–309. doi: 10.1046/j.1365-2036.1997.155329000.x. [DOI] [PubMed] [Google Scholar]
  22. Tucci A., Corinaldesi R., Stanghellini V., Paparo G. F., Gasperoni S., Biasco G., Varoli O., Ricci-Maccarini M., Barbara L. One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci. 1993 Sep;38(9):1670–1673. doi: 10.1007/BF01303176. [DOI] [PubMed] [Google Scholar]
  23. Versalovic J., Shortridge D., Kibler K., Griffy M. V., Beyer J., Flamm R. K., Tanaka S. K., Graham D. Y., Go M. F. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1996 Feb;40(2):477–480. doi: 10.1128/aac.40.2.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weil J., Bell G. D., Powell K., Morden A., Harrison G., Gant P. W., Jones P. H., Trowell J. E. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther. 1990 Dec;4(6):651–657. doi: 10.1111/j.1365-2036.1990.tb00513.x. [DOI] [PubMed] [Google Scholar]
  25. Wurzer H., Rodrigo L., Stamler D., Archambault A., Rokkas T., Skandalis N., Fedorak R., Bazzoli F., Hentschel E., Mora P. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. Aliment Pharmacol Ther. 1997 Oct;11(5):943–952. doi: 10.1046/j.1365-2036.1997.00223.x. [DOI] [PubMed] [Google Scholar]
  26. Xia H., Keane C. T., Beattie S., O'Morain C. A. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother. 1994 Oct;38(10):2357–2361. doi: 10.1128/aac.38.10.2357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yousfi M. M., el-Zimaity H. M., al-Assi M. T., Cole R. A., Genta R. M., Graham D. Y. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Apr;9(2):209–212. doi: 10.1111/j.1365-2036.1995.tb00374.x. [DOI] [PubMed] [Google Scholar]
  28. de Boer W. A., Driessen W. M., Jansz A. R., Tytgat G. N. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol. 1995 Dec;7(12):1189–1194. doi: 10.1097/00042737-199512000-00011. [DOI] [PubMed] [Google Scholar]
  29. de Boer W. A., van Etten R. J., Lai J. Y., Schneeberger P. M., van de Wouw B. A., Driessen W. M. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection. Helicobacter. 1996 Sep;1(3):145–150. doi: 10.1111/j.1523-5378.1996.tb00028.x. [DOI] [PubMed] [Google Scholar]
  30. de Boer W., Driessen W., Jansz A., Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995 Apr 1;345(8953):817–820. doi: 10.1016/s0140-6736(95)92962-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES